1Hoist Hansen C, Hamers M J, Johanneseen B E, et al. Soluble urokinase receptor released from human carcinoma cells: a plasma panancter for xenograft tumor studies[J]. Br J Cancer, 1999,81(1) :203-206. 被引量：1
2Gyetko M R, Chen G H, McDonald R A, et al. Urokinase is required for the pulmonary inflammation response to Cryptococcus netoformans [ J ]. J Clin Invest, 1996,98(8) :1818-1826. 被引量：1
3Vassalli J D, Baceino D. A cellular binding site for the Mr.55 000 form of the human plasminogen activator, urokinase [ J]. J Cell Bid, 1985, 100(1):86-91. 被引量：1
4Mizuami I F, Faulkner N E,Gyetko M R,et al. Enzyme-liked immyunoabaorbert assay detection of a soluble form of urokinase plasminogen activator receptor in vivo [J].Blood,1995,86(1):203-211. 被引量：1
8Araki S, Haneda M, Koya D. Keduction in microalb- minutia as an integrated indicator for renal and cardio-rascular risk reduction in patients with type 2 diabete. Diabetes, 2007,56:1727-1730 PMID: 17360976 [ PubMed - indexed for MEDLINE ]. 被引量：1
9Abu E1-Asrar AM, AI-Mezaine HS. Advances in the treatment of diabetic[J]. Saudi J Ophthalmol, 2011, 25(2) : 113-122. 被引量：1
10Pai A, E1 Shafei MM, Mohammed OA, et al. Current concepts in intravitreal drug therapy for diabetic retinopathy [ J ]. Saudi J Ophthalmol, 2010, 24(4): 143-149. 被引量：1
